[324 Pages Report] Booming at an impressive CAGR of 4.7%, the global gamma linolenic acid market is projected to grow from a valuation of US$ 20 million in 2022 to US$ 31.6 million by 2032.
The demand for gamma linolenic acid is surging globally owing to the increasing adoption of healthy lifestyle amongst consumers. Gamma linolenic acid acts as omega-6 which is essential for maintaining heart health. Gamma linolenic acid can be integrated organically by humans, or several food ingredients can be consumed to meet the desired requirements.
| Report Attribute | Details |
|---|---|
| Gamma Linolenic Acid Market Value (2022) | US$ 20 Million |
| Gamma Linolenic Acid Market Anticipated Forecast Value (2032) | US$ 31.6 Million |
| Gamma Linolenic Acid Market Projected Growth Rate (2022-2032) | 4.7% |
The sales of Gamma Linolenic Acid (GLA) are surging due to its several medicinal properties. Gamma linolenic acid is polyunsaturated fatty substance and has a vital function in maintaining human health. This substance is found in several plant seed oils such as evening primrose, borage, and black currant.
There is an increase in the demand for gamma linolenic acid as majority population use this substance for conditions such as eczema (atopic dermatitis), diabetes (diabetic neuropathy), high blood pressure, arthritis, and several other health conditions. However, there exists no firm scientific evidence to back these uses and their effectiveness.
Our body does not generate omega-6 fatty acids, and therefore, they are obtained through various supplements and diets. Besides heart health, omega-6 fatty acids are also used for insulin utilization and mood balance. When gamma linolenic acid is consumed, the body converts it into a particular which alleviates any inflammation.
The gamma linolenic acid market growth is flourishing owing to its use in several industries and in pharmaceutical, dietary supplements, animal nutrition, cosmetics, and food and beverage industries.
Gamma linolenic acid is used in the treatment of medical conditions such as high cholesterol, metabolic syndrome, diabetic nerve pain, chronic fatigue syndrome, deficit-hyperactivity disorder, and for polyps in the mouth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising prevalence of rheumatoid arthritis is predicted to promote the demand for gamma linolenic acid, and this is helping the growth of global gamma linolenic acid market. In 2017, the Arthritis Foundation published a study which stated that approximately 54.4 million Americans are suffering from doctor-diagnosed arthritis.
In arthritis, swelling and pain in joints is the most common symptoms. In such cases, consuming gamma linolenic acid is an effective option as it decreases inflammation and helps in preventing arthritis. Amongst the global consumers awareness related to health is on the rise and there has been a huge alteration in their lifestyle. This factor is said to boost the growth of gamma linolenic acid market.
Nowadays, consumers are preferring products which have natural and nutritive ingredients and offer health benefits. Therefore, as the number of arthritis cases increases, the demand for gamma linolenic acid induced products is anticipated to rise.
Since the human body does not synthesize gamma linolenic acid, we must rely on external sources to meet the requirements of the human body. There occur some metabolic changes in the body due to the deficiency of gamma linolenic acid. Hence, the reliance on external source to fulfil the gamma linolenic acid requirement is anticipated to be one of the factors responsible for the growth of global gamma linolenic acid market.
During the forecast period, the market share of gamma linolenic acid is said to flourish owing to its numerous health benefits. This substance is also used as a medication in several health conditions such as menopause, eczema, and allergies. Moreover, consuming gamma linolenic acid reduces the symptoms associated with nerve damage in diabetic patients.
Certain studies have proven that gamma linolenic acid assists in slowing the tumour growth and additionally helps in enhancing the effectiveness of some anti-cancer drugs. All these abundant benefits of this substance are projected to rise the demand in the pharmaceutical and dietary supplement.
In some cases, side effects linked to the over consumption of gamma linolenic acid could be a restraining factor of the global market.
The Arthritis Foundation says that by the year 2040, the number of individuals in the United States suffering from doctor-diagnosed arthritis is forecasted to increase by 49% and impact nearly 78.4 million population in the U.S. The increasing prevalence of arthritis in North America is anticipated to have a lucrative impact on the gamma linolenic acid market.
From the past few years, the U.S. and European based cosmetic manufacturers have been striving to raise their profit margins. One of the prime business tactics followed by them is business process outsourcing.
Developing countries like India, China, Indonesia, etc., in the Asia Pacific regions have been proven to be production hubs by most of the pharmaceutical and cosmetic manufacturers. This has resulted in the demand for raw materials in this region. Gamma linolenic acid finds its major demand in the Asia Pacific markets.
Principal Consultant
A few of the key players in the gamma linolenic acid market include Merck KGaA, Enzo Life Sciences, Inc., Cayman Chemical, Thermo Fisher Scientific, Cherish Pharma, Changsha Vigorous-Tech, Charkit Chemical, Penta Manufacturing, Acme, Cailà & Parés.
In January 2022, the world leader in serving science, Thermo Fisher Scientific Inc., and Pepro Tech, Inc., announced its acquisition of Pepro Tech in December 2021, for a total cash purchase price of around $1.85 billion.
Market manufacturers of many industries are said to aim on creating products which assist in delivering an efficient solution for arthritis. The manufacturers of gamma linolenic acid have opportunities to enhance the promotional and marketing strategies. This will result in more awareness pertaining to health benefits of gamma linolenic acid and additionally increase its use in several end use industries.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 3.4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global gamma linolenic acid market is set to advance at a CAGR of 4.7% from 2022 to 2032.
Gamma linolenic acid market is projected to hold a market share of US$ 31.6 million by 2032.
Some of the key players holding major global gamma linolenic acid market share are Merck KGaA, Enzo Life Sciences, Inc., Cayman Chemical, Thermo Fisher Scientific, Cherish Pharma, Changsha Vigorous-Tech, Charkit Chemical, Penta Manufacturing, Acme, Cailà & Parés.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Nature
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Nature, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Nature, 2022-2032
5.3.1. Organic
5.3.2. Conventional
5.4. Y-o-Y Growth Trend Analysis By Nature, 2017-2021
5.5. Absolute $ Opportunity Analysis By Nature, 2022-2032
6. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Form, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Form, 2022-2032
6.3.1. Powder
6.3.2. Liquid
6.4. Y-o-Y Growth Trend Analysis By Form, 2017-2021
6.5. Absolute $ Opportunity Analysis By Form, 2022-2032
7. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By End-use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By End-use, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By End-use, 2022-2032
7.3.1. Food and Beverage
7.3.2. Dietary Supplements and Functional Foods
7.3.3. Pharmaceutical Industry
7.3.4. Cosmetic and Personal Care
7.3.5. Animal Nutrition
7.4. Y-o-Y Growth Trend Analysis By End-use, 2017-2021
7.5. Absolute $ Opportunity Analysis By End-use, 2022-2032
8. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Nature
9.2.3. By Form
9.2.4. By End-use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Nature
9.3.3. By Form
9.3.4. By End-use
9.4. Key Takeaways
10. Latin America Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Mexico
10.2.1.2. Brazil
10.2.1.3. Rest of Latin America
10.2.2. By Nature
10.2.3. By Form
10.2.4. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Nature
10.3.3. By Form
10.3.4. By End-use
10.4. Key Takeaways
11. Europe Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. BENELUX
11.2.1.7. Russia
11.2.1.8. Rest of Europe
11.2.2. By Nature
11.2.3. By Form
11.2.4. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Nature
11.3.3. By Form
11.3.4. By End-use
11.4. Key Takeaways
12. East Asia Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Nature
12.2.3. By Form
12.2.4. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Nature
12.3.3. By Form
12.3.4. By End-use
12.4. Key Takeaways
13. South Asia & Pacific Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. ASEAN
13.2.1.3. Australia and New Zealand
13.2.1.4. Rest of South Asia & Pacific
13.2.2. By Nature
13.2.3. By Form
13.2.4. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Nature
13.3.3. By Form
13.3.4. By End-use
13.4. Key Takeaways
14. MEA Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. Turkey
14.2.1.3. South Africa
14.2.1.4. Rest of MEA
14.2.2. By Nature
14.2.3. By Form
14.2.4. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Nature
14.3.3. By Form
14.3.4. By End-use
14.4. Key Takeaways
15. Key Countries Gamma Linolenic Acid Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Nature
15.1.2.2. By Form
15.1.2.3. By End-use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Nature
15.2.2.2. By Form
15.2.2.3. By End-use
15.3. Mexico
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Nature
15.3.2.2. By Form
15.3.2.3. By End-use
15.4. Brazil
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Nature
15.4.2.2. By Form
15.4.2.3. By End-use
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Nature
15.5.2.2. By Form
15.5.2.3. By End-use
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Nature
15.6.2.2. By Form
15.6.2.3. By End-use
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Nature
15.7.2.2. By Form
15.7.2.3. By End-use
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Nature
15.8.2.2. By Form
15.8.2.3. By End-use
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Nature
15.9.2.2. By Form
15.9.2.3. By End-use
15.10. BENELUX
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Nature
15.10.2.2. By Form
15.10.2.3. By End-use
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Nature
15.11.2.2. By Form
15.11.2.3. By End-use
15.12. China
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Nature
15.12.2.2. By Form
15.12.2.3. By End-use
15.13. Japan
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Nature
15.13.2.2. By Form
15.13.2.3. By End-use
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Nature
15.14.2.2. By Form
15.14.2.3. By End-use
15.15. India
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Nature
15.15.2.2. By Form
15.15.2.3. By End-use
15.16. ASEAN
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Nature
15.16.2.2. By Form
15.16.2.3. By End-use
15.17. Australia and New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Nature
15.17.2.2. By Form
15.17.2.3. By End-use
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Nature
15.18.2.2. By Form
15.18.2.3. By End-use
15.19. Turkey
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Nature
15.19.2.2. By Form
15.19.2.3. By End-use
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Nature
15.20.2.2. By Form
15.20.2.3. By End-use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Nature
16.3.3. By Form
16.3.4. By End-use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Merck KGaA
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Enzo Life Sciences, Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Cayman Chemical
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Thermo Fisher Scientific
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Cherish Pharma
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. ACME
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Caila and Pares
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. DSM
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Synerzine
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Food and Beverage Insights
View Reports
Gamma Linolenic Acid Market
